Curcumin loaded organically modified silica (ORMOSIL) nanoparticle; a novel agent for cancer therapy Online publication date: Thu, 04-Oct-2012
by Amit K. Dinda; Chandravilas K. Prashant; Saba Naqvi; J. Unnithan; Mohd. Samim; Amarnath Maitra
International Journal of Nanotechnology (IJNT), Vol. 9, No. 10/11/12, 2012
Abstract: Curcumin is a polyphenol compound extracted from the rhizome of turmeric (Curcuma longa) and has a well established anticancer property. However poor aqueous solubility is a major hindrance for its bioavailability and therapeutic use. Nanoparticle based system can be developed to overcome this problem. Present study has been undertaken with curcumin loaded organically modified silica (ORMOSIL) nanoparticle (NP) to assess its anticancer property. In comparison to void ORMOSIL NP the curcumin loaded NP has shown marked cytotoxicity on hepatocellular carcinoma (HepG2) cells as well as reduction of Ehrlich Ascites Tumour (EAT) cell induced experimental solid tumour following intratumoral injection. There is increased apoptosis of cancer cells due to curcumin induced enhanced intracellular generation of reactive oxygen species (ROS). Thus curcumin loaded ORMOSIL NP may have a potential for use as anticancer therapy replacing or substituting more toxic anti-mitotic drugs and radiation.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Nanotechnology (IJNT):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com
Our Blog 
Follow us on Twitter 
Visit us on Facebook